Daily Stock Ratings & Price Targets
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Market Cap
Any
Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
|---|---|---|---|---|---|---|---|---|---|
 xxxxxxxxxxxxxxxxxx | BUY $110 | ― | 3.10% | Reiterated | |||||
| Ralliant Corporation | HOLD $78 | ― | 0.10% | Initiated | Ralliant: Strong Post-Writedown Rally and Structural Growth Prospects, But Limited Near-Term Visibility Justify Hold Rating | |||
 xxxxxxxxxxxxxxxxxx | BUY $295 | ― | 13.20% | Reiterated | |||||
| Wise PLC Class A | BUY $11.4 | ― | -5.00% | Assigned | ||||
| xxxxxxxxxxxxxxxxxx | BUY $75→$85 | ― | 12.90% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $53→$55 | ― | 11.60% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | HOLD $30→$47 | ― | 1.70% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $190→$155 | ― | 12.90% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $49→$51 | ― | 11.60% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $65→$70 | ― | 12.90% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $90 | ― | 12.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | SELL $105 | ― | 12.90% | Assigned | |||||
 xxxxxxxxxxxxxxxxxx | HOLD $9 | ― | 9.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $800 | ― | 12.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | BUY $12 | ― | 12.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | BUY $760 | ― | 12.90% | Assigned | |||||
| Elevance Health | BUY $457 | ― | -5.40% | Assigned | Analysts' Opinions Are Mixed on These Healthcare Stocks: Iovance Biotherapeutics (NASDAQ: IOVA), Elevance Health (NYSE: ELV) and InnovAge Holding (NASDAQ: INNV) | |||
| xxxxxxxxxxxxxxxxxx | BUY $175 | ― | 12.90% | Assigned | |||||
 xxxxxxxxxxxxxxxxxx | BUY $11 | ― | 30.60% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | BUY $160 | ― | 12.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | BUY $124 | ― | 9.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | BUY $28 | ― | 30.60% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | BUY $300 | ― | 12.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | BUY $640 | ― | 12.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | BUY $150 | ― | 12.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | BUY $37 | ― | 30.60% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | SELL $715 | ― | 12.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | SELL $141 | ― | 9.90% | Assigned | |||||
| xxxxxxxxxxxxxxxxxx | BUY $340 | ― | 12.90% | Assigned | |||||
| Prologis | BUY $156 | ― | 0.00% | Assigned | Prologis (PLD) Gets a Buy from Barclays | |||
| xxxxxxxxxxxxxxxxxx | HOLD ― | ― | 5.40% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | HOLD $300→$225 | ― | 13.80% | Downgraded | |||||
 xxxxxxxxxxxxxxxxxx | HOLD $47 | ― | 13.50% | Initiated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $51 | ― | 7.20% | Initiated | |||||
 xxxxxxxxxxxxxxxxxx | BUY $41→$34 | ― | 10.00% | Upgraded | |||||
| xxxxxxxxxxxxxxxxxx | BUY $384 | ― | 18.50% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $98 | ― | 7.20% | Initiated | |||||
 xxxxxxxxxxxxxxxxxx | BUY $31 | ― | 22.20% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $14→$7.45 | ― | 21.30% | Downgraded | |||||
 xxxxxxxxxxxxxxxxxx | BUY $270→$330 | ― | 6.20% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $225→$311 | ― | 6.20% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $210→$250 | ― | 6.20% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $70→$86 | ― | 6.20% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $56 | ― | 13.20% | Initiated | |||||
 xxxxxxxxxxxxxxxxxx | BUY $99→$96 | ― | 27.00% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $60→$62 | ― | 27.00% | Reiterated | |||||
 xxxxxxxxxxxxxxxxxx | HOLD $58→$60 | ― | 15.50% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $53→$55 | ― | 15.50% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | BUY $48→$50 | ― | 20.50% | Reiterated | |||||
| xxxxxxxxxxxxxxxxxx | HOLD $32→$33 | ― | 15.50% | Reiterated |
Rows:
